Triazole Linkers for Conjugate Synthesis via Click Chemistry
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing targetable conjugates for cancer treatment are complex, requiring multiple synthetic steps and the use of orthogonal protecting groups, which can limit their accessibility and increase synthesis time and costs.
Innovation Solution
A method involving a mild and selective cycloaddition reaction to form a triazole ring, allowing for the direct transformation of azide or alkyne protecting groups into reactive moieties, reducing the need for deprotection steps and enabling the use of a broader range of protecting groups, thus simplifying the synthesis of conjugates with improved pharmacokinetic properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current methods for synthesizing targetable conjugates are used, then the conjugates can be produced with required functionality, but the synthesis process becomes complex requiring multiple synthetic steps and orthogonal protecting groups
Solution Approach 1:
The invention changes the chemical reactivity parameters by using copper-catalyzed azide-alkyne cycloaddition (CuAAC) to form triazole linkers. This click chemistry approach transforms the synthesis from requiring multiple protection/deprotection steps to a single-step condensation reaction, dramatically simplifying the process while maintaining conjugate functionality
Solution Approach 2:
The invention extracts and eliminates the need for orthogonal protecting groups from the synthesis pathway. By using bioorthogonal chemistry between azide and alkyne groups that do not interfere with biological functional groups, the complex protecting group manipulations are completely removed from the synthesis protocol
2Manufacturing precision
If multiple synthetic steps and orthogonal protecting groups are used, then the required conjugate structure can be achieved, but synthesis time and costs increase
Solution Approach 1:
The invention performs preliminary action by pre-installing azide or alkyne functional groups on the therapeutic agent and targeting moiety separately before final conjugation. This allows each component to be prepared independently with standard chemistry, then rapidly assembled via click chemistry, reducing total synthesis time while maintaining structural precision
Solution Approach 2:
The invention segments the conjugate synthesis into modular components: a targeting moiety, a therapeutic agent, and triazole-based linker units. Each segment can be synthesized and characterized independently, then assembled through the click chemistry reaction, improving both time efficiency and structural control
3Ease of manufacture
If conventional synthesis methods are used, then the conjugate can be formed, but accessibility and ease of synthesis are limited
Solution Approach 1:
The invention substitutes complex mechanical protecting group manipulation with a chemical catalyst system. The copper catalyst enables direct cycloaddition between azide and alkyne groups under mild conditions, replacing the need for multiple mechanical deprotection steps and making the synthesis accessible to broader laboratories
Solution Approach 2:
The triazole linker formed by click chemistry serves multiple functions simultaneously: it provides stable covalent bonding between components, introduces desirable pharmacokinetic properties, and creates a bioorthogonal structure that doesn't interfere with biological activity. This multi-functionality simplifies the overall synthetic design
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach simplifies the synthesis of conjugates, reduces the number of synthetic steps, and enhances their pharmacokinetic properties, such as water solubility and stability, while maintaining control over the release of therapeutic moieties at specific sites.
Implementation Method 1
A method involving a mild and selective cycloaddition reaction to form a triazole ring, allowing for the direct transformation of azide or alkyne protecting groups into reactive moieties
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
This invention relates to compounds comprising one or more therapeutic and/or diagnostic moieties and one or more functional moieties linked together via one or more triazole-containing linkers and to their intermediates and methods of their preparation. The triazole-containing linker may optionally contain one or more conditionally-cleavable or conditionally- transformable moieties and one or more spacer systems in between said moiety/moieties and the one or more therapeutic and/or diagnostic moieties.